Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

New phase II trial evaluates CBP-201 for moderate to severe atopic dermatitis

July 6, 2020

Akeso begins first-in-human study of AK-120 for atopic dermatitis

July 2, 2020

Amniox begins first phase III trial of TTAX-01 in diabetic foot ulcers

July 1, 2020

Ilumya approved in Japan for plaque psoriasis

July 1, 2020

FDA approves IND for SFA-002 study in psoriasis

July 1, 2020

AOBiome begins phase IIb study with B-244 for pruritus in atopic dermatitis

June 30, 2020

Boehringer Ingelheim identifies new pantetheinase inhibitors

June 29, 2020

Positive phase I/IIa results presented for AIV-001 in dermal scarring

June 29, 2020

Patient genetic variants linked to wound microbiomes

June 26, 2020

Reistone begins dosing in phase II study of SHR-0302 for alopecia areata

June 19, 2020

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...